Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VTAMA in Intertriginous Plaque Psoriasis
NCT05680740Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Dec 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tapinarof in plaque psoriasis, sponsored by Organon & Co.. Started Dec 2022; status: completed.
02
Drugs
tapinarof
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT05680740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05680740.